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ABSTRACT: (+)-Stephadiamine is an unusual alkaloid 
isolated from the vine Stephania japonica. It features a 
norhasubanan skeleton, and contains two adjacent α-
tertiary amines, which renders it an attractive synthetic 
target. Here, we present the first total synthesis of steph-
adiamine, which hinges on an efficient cascade reaction 
to implement the aza[4.3.3]propellane core of the alka-
loid. The α-aminolactone moiety in a highly hindered 
position was installed via Tollens reaction and Curtius 
rearrangement. Useful building blocks for the asymmet-
ric synthesis of morphine and (nor)hasubanan alkaloids 
are introduced. 
INTRODUCTION. Morphine and hasubanan alkaloids 
have inspired synthetic chemists for decades. Following the 
pioneering work of Gates in 1952,[1] more than 30 total and 
formal syntheses of morphine (1) have been published,[2] 
some of them very recently.[3] Many syntheses of hasu-
banonine (2) and its congeners have appeared in the litera-
ture since the isolation of the first hasubanan alkaloid was 
reported by Konto et al. in 1951.[4] Therefore, it is surpris-
ing that one of the most beautiful and challenging mole-
cules in the series, viz. stephadiamine (3), has been virtual-
ly ignored by the synthetic community. 
(+)-Stephadiamine (3) was isolated from the snake vine 
Stephania japonica in 1984 by Taga et al. and is the only 
example of a norhasubanan alkaloid, which features a con-
tracted C-ring.[5] The absolute configuration of the natural 
product was elucidated by single crystal X-ray analysis of a 
benzoylated derivative of 3. Although S. japonica is used in 
traditional Chinese medicine to treat asthma, fever and 
digestive disorders,[6] the biological activity of stephadia-
mine (3) has yet to be established due to a paucity of mate-
rial. Structurally, 3 features a unique pentacyclic skeleton 
arranged around an aza[4.3.3]propellane core. It bears a 
total of four stereocenters, including a benzylic quaternary 
carbon and two adjacent α-tertiary amines in a cis-1,2 rela-
tionship.[7] One of these is part of an α-amino δ-lactone 
which contains the benzylic oxygen often found in hasu-
banan alkaloids.  
Scheme 1. Natural products related to stephadiamine 
and retrosynthesis.  
 
INITIAL SYNTHETIC PLAN. Motivated by these unu-
sual structural features and our general interest in hasu-
banan alkaloids,[8] we set out to explore the synthesis of 
stephadiamine (3). Our initial strategy called for the instal-
lation of both α-tertiary amines and the [4.3.3]-
azapropellane core through a late-stage and intramolecular 
cis-1,2-diamination (Scheme 1). The requisite diamination 
substrate 4, a cyclopentene carboxylate, could be traced 
back to conjugated ester 5 via reductive aldol condensation. 
Ketone 5, in turn, could be accessed from the known β-
tetralone 6.[9] Tetralones with this substitution pattern are 
popular intermediates in the synthesis of hasubanan and 
morphinan alkaloids,[10] but most reported preparations are 
lengthy, require expensive catalysts and starting materials, 
or are difficult to scale up.[9] We therefore first set out to 
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 develop a one-pot procedure starting from the commercial-
ly available carboxylic acid 7. 
Scheme 2. Synthesis of tetralone 8 and attempted 
aldol condensation.  
 
aReagents and conditions: (a) oxalyl chloride (1.2 eq.), DMF (cat.), 
CH2Cl2, 0 °C, 10 min, then r.t., 3 h; (b) AlCl3 (6 eq.), ethene (1 atm), 
−32 °C, 6 h, 48% over 2 steps; (c) pyrrolidine (1.3 eq.), toluene, MgSO4, 
100 °C, 24 h, then BrCH2CN (1.6 eq.), 100 °C, 28 h, 89%; (d) NaH 
(1.1 eq.), THF, 0 °C, 30 min, then allyl chloroformate (1.0 eq.), 0 °C, 1 h, 
98%; (e) Pd2(dba)3 (2.5 mol%), PPh3 (6.25 mol%), r.t., 12 h, 84%; (f) HG 
II (7 mol%), methyl acrylate (15 eq.), toluene, 48 h, 97%; (g) 
Cu(OAc)2·H2O (0.5 eq.), rac-BINAP (0.5 eq.), TMDS (1 eq.), THF, r.t., 
24 h → 1 M HCl, r.t., 1 h, 60%. BINAP = 2,2'–Bis(diphenylphosphino)–
1,1'–binaphthyl; dba = dibenzyli-deneacetone, HG II = Hoveyda−Grubbs 
cat. 2nd generation, TMDS = 1,1,3,3-tetramethyldisiloxane  
Conversion of 7 to the corresponding acyl chloride, fol-
lowed by treatment with AlCl3 under an ethene atmosphere 
provided tetralone 6 in good overall yield and on a multi-
gram scale (Scheme 2).[9] Low temperatures were neces-
sary in this reaction to prevent competing cyclization to the 
corresponding benzofuranone by participation of the adja-
cent methoxy group.[11] Alkylation of 6 with bromoacetoni-
trile under Stork conditions,[12] followed by conversion to 
the enol carbonate and decarboxylative Tsuji allylation 
yielded tetralone 8 as a racemate with the benzylic quater-
nary stereocenter in place.[13] A subsequent cross metathesis 
with methyl acrylate then provided the conjugated ester 5 
in excellent yield.[14] 
DISCOVERY OF A CASCADE REACTION. With ester 
5 in hand, we investigated a reductive aldol reaction to 
form the five-membered ring.[15] Using Stryker’s reagent, 
we only isolated the 1,4-reduction product (11) accompa-
nied by lactone 9, which is presumably formed by attack of 
a tertiary alkoxide onto the nitrile followed by hydrolysis, 
and trace amounts of the anticipated aldol product 10. Al-
ternative hydride sources such as L-Selectride, 
Rh(cod)2OTf/PPh3/H2, and a copper hydride formed in situ 
from Cu(OAc)2, TMDS, and rac-BINAP only increased the 
yield of 9 (Scheme 2 and SI). The single crystal X-ray 
structure of 9 revealed a perfect anti-periplanar arrange-
ment of the C–H-bond next to the methyl ester and the 
lactone C–O bond. Despite this, we were unable to promote 
an elimination to the corresponding cyclopentene carbox-
ylate. 
Next, we attempted the aldol addition under conditions, 
which could enable the clean isolation of β-hydroxy ketone 
10 with the nitrile intact (Scheme 2). In preparation for this, 
we hydrogenated 5 to obtain the saturated ester 11. Upon 
exposure of 11 to in situ generated sodium methoxide in 
methanol at 75 °C, we isolated two new products in excel-
lent combined yield. To our pleasant surprise, these were 
identified as the pyrrolidinone 16 and its C7-epimer 17, 
both of which contain the aza[4.3.3]propellane core of 
stephadiamine (3) (Scheme 3). They are formed in a reac-
tion cascade that presumably involves a transiently formed 
ester enolate 12.
Scheme 3. Cascade reaction for the construction of the aza[4.3.3]propellane core. 
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 aReagents and conditions: (a) Pd-C (10wt%), H2 (1 atm), EtOAc, r.t., 12 h, 97%; (b) Na (1.2 eq.), MeOH, 75 °C, 24 h, 91% on 24 mmol scale, 99% on 
3 mmol scale.
Intramolecular aldol addition then affords alkoxide 13, 
which undergoes addition to the nitrile, elimination of the 
intermediary imidate (14→15), and conjugate re-addition 
in an aza-Michael reaction to yield the diastereomeric pyr-
rolidinones. This sequence of events resembles a cascade 
that was used in Inubushi’s synthesis of cepharamine,[16] 
although in our case we construct a different heterotricyclic 
system with an additional stereocenter in a remarkably 
efficient overall reaction. 
INSTALLATION OF THE DIAMINE. At this point, 
completion of stephadiamine (3) formally required N-
methylation, α-amination and closure of the lactone via 
benzylic functionalization. While the first task could be 
achieved by treating the diastereomeric mixture of lactams 
16 and 17 with NaH and MeI, the second turned out to be 
exceedingly difficult due to the steric hindrance of the 
azapropellane system.  
Attempted deprotonation of 16/17 and exposure to a variety 
of electrophilic amination reagents failed to give any iden-
tifiable products and mostly resulted in the recovery of 
starting materials. Similarly, carboxylation under a variety 
of conditions, which was intended to enable a Curtius rear-
rangement for the installation of the second α-tertiary 
amine, were unsuccessful. In addition, all efforts to epimer-
ize the ester and to form a silyl ketene acetal failed, sug-
gesting that the deprotonation step was the source of our 
frustrations. 
In an attempt to increase the acidity of the α-hydrogen, we 
reduced the ester moiety to the corresponding aldehyde 18 
using DIBAL-H. Again, we only observed either decompo-
sition or no reaction when we tried α-aminations or car-
boxylation reactions. We therefore decided to resort to 
chemistry that would employ one of the smallest base and 
electrophile combinations possible: the Tollens reaction 
(aldol reaction followed by crossed Cannizzaro 
reaction).[17] Exposure of aldehyde 18 to an excess of KOH 
and formaldehyde at elevated temperatures over two days 
afforded diol 19, which features a quaternary carbon in a 
highly congested position. 
To convert the 1,3-diol into the α-amino lactone moiety we 
tried to oxidize it to the corresponding malonate or carboxy 
lactone. This failed, as did our efforts to selectively protect 
one of the two primary alcohols. Therefore, we decided to 
differentiate them via benzylic oxidation. After screening 
multiple conditions, this could be accomplished using DDQ 
and AcOH at elevated temperatures yielding pyrane 20.[18] 
.[18] With one hydroxymethyl group isolated, we turned to 
the implementation of the second α-tertiary amine. To this 
end, the primary alcohol 20 was converted to the carbox-
ylic acid using Ley’s conditions[19] followed by a Pinnick–
Lindgren oxidation.[20] Formation of the acyl azide and 
subsequent Curtius rearrangement in the presence of benzyl 
alcohol smoothly gave the Cbz-protected cis-1,2-diamine 
21.  
Scheme 4. Installation of the diamine. 
  
 aReagents and conditions: (a) NaH (1.2 eq.), MeI (1.2 eq.), DMF, 30 °C, 
14 h, 91%; (b) DIBAL-H (2.5 eq.), CH2Cl2, 78 °C, 3.5 h, 79%; (c) KOH 
(10 eq.), formaldehyde (10 eq.), MeOH, 50 °C, 48 h, 41% (d) DDQ 
(10 eq.), AcOH (10 eq.), 4Å MS, DCE, 75 °C, 5 h, 92%; (e) TPAP 
(0.05 eq.), NMO (10 eq.), 4Å MS, CH2Cl2, r.t., 1 h, 93%; (f) NaClO2 
(9.2 eq.), NaH2PO4 (9.2 eq.), 2-methyl-2-butene, t-BuOH/H2O, r.t., 3 h, 
96%; (g) DPPA (1.5 eq), NEt3 (3 eq.), toluene, r.t., 1 h, then 100 °C, 1 h, 
then BnOH (5 eq.), 100 h, 14 h, 84%; (h) BF3OEt2 (30 eq.), Ac2O, 0 °C 
to r.t., 6.5 h, 84%; (i) Boc2O (2 eq.), NEt3 (2 eq.), DMAP (0.1 eq.), THF, 
r.t., 17 h, 65%; (j) Cs2CO3 (0.5 eq.), MeOH, r.t., 12 h, 96%; (k) TPAP 
(0.02 eq.), NMO (4.5 eq.), 4Å MS, CH2Cl2, r.t., 20 min, 80%; (l) I2 
(10 eq.), MeCN, r.t., 24 h, 91 %; (m) I2 (10 eq.), KOH (10 eq.), MeOH, 
r.t., 15 min, 94 %. Cbz = carboxybenzyl, DIBAL-H = diisobutylaluminum 
hydride, DDQ = 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, 
MS = molecular sieves, TPAP = tetrapropyl-ammonium perruthenate, 
NMO = N-Methylmorpholine N-oxide, DPPA = diphenylphosphoryl 
.azide, Boc = tert-butyloxycarbonyl, DMAP = 4-dimethylaminopyridine. 
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Scheme 5. Completion of the synthesis. 
 
 
aReagents and conditions: (a) NBS (1.05 eq.), H2O/THF, 0 °C, 90 min. then r.t., 90 min., 50%; (b) Bu3SnH (10 eq.), AIBN (1 eq.), benzene, 90 °C, 3 h, 
98%.; (c) DMSBH3 (10 eq.), THF, 0 °C to r.t., 20 h, then 0 °C, AcOH, 57%, 99% brsm; (d) TFA, DCM, 0 °C, 90 min, <90%. NBS = N-
bromosuccinimide, AIBN = α,α′-azo-isobutyronitrile. 
COMPLETION OF THE SYNTHESIS. At this stage, 
the completion of the synthesis would only require reduc-
tion of the lactam in 21, oxidation of its tetrahydropyran 
to a lactone and deprotection of the primary amine. Alt-
hough we were aware that chances were slim due to the 
presence of a benzylic C,H-bond and a very electron-rich 
rich aromatic ring, we first explored the oxidation under a 
variety of conditions (RuO4, KMnO4, CrO3, DMDO, 
White–Chen catalyst).  
Since none of the conditions led to any isolable products, 
we abandoned the direct oxidation of the ether 21 and 
decided to cleave the C11–O bond and oxidize C8 to the 
corresponding carboxylic acid followed by reclosure of 
the heterocycle. The reductive opening of benzylic ethers 
is a common transformation that can be achieved via 
hydrogenation or Lewis acid activation and hydride trans-
fer.[21] However, exposure of 21 to PtO2/H2, Pd-C/H2, 
TFA/Et3SiH or AcOH/Et3SiH failed to promote the reduc-
tive cleavage of the C,O bond. We thus investigated dif-
ferent conditions for the conversion of the benzyl ether 
into the corresponding styrene via elimination. Since a 
variety of Lewis acids (TMSOTf, TMSCl, BF3·OEt2) in 
different solvents did not afford the desired product, we 
reasoned that the elimination could be reversible and 
added TFAA and Ac2O to passivate the pendant alcohol. 
TFAA decomposed the starting material, but the use of 
excess BF3⋅OEt2 in acetic anhydride allowed for the isola-
tion of oxazolidinone 22. This compound was treated then 
with Boc2O anhydride and then hydrolyzed to yield Boc-
protected amino alcohol 23.[22] 
The completion the synthesis required careful orchestra-
tion of redox reactions carried out on highly hindered and 
sensitive substrates. Ley oxidation of primary alcohol 23 
to the corresponding aldehyde 24, followed by attempted 
iodine mediated oxidation in acetonitrile, yielded the 
unusual oxazolidinone acetal 25. Multiple standard oxida-
tion conditions, led to similar products or resulted in de-
composition. However, treatment with iodine in methanol 
cleanly yielded methyl ester 26.[23] Since this ester could 
not be hydrolyzed under a variety of conditions, we at-
tempted the direct cyclization to lactone 28 or 29. Acid-
catalyzed lactonization and conventional halolactoniza-
tions were unsuccessful, presumably due to an unfavora-
ble conformation of the ester. Using NBS in the presence 
of H2O, however, we were able to regio- and stereoselec-
tively install an intermediate bromohydrin 27, character-
ized by mass spectrometry, which subsequently under-
went lactonization.[24] The secondary bromide of the re-
sultant halolactone 28 was removed under radical condi-
tions to obtain the pentacyclic lactone 29, the structure of 
which was confirmed by single X-ray analysis. In the 
final steps of the synthesis, the lactam moiety in 29 was 
reduced to the corresponding pyrrolidine using borane 
dimethyl sulfide complex.[25] Close monitoring of the 
reaction was crucial to avoid competing reduction of the 
strained yet sterically hindered six-membered lactone. 
Acidic deprotection of the primary amine finally gave 
racemic stephadiamine (3). The deprotection step was 
carried out in deuterated dichloromethane and monitored 
by NMR as slow cleavage of the lactone was observed 
upon exposure to TFA. The analytical data of synthetic 3 
were in complete agreement with the limited data availa-
ble from the original publication.  
ASYMMETRIC APPROACH. In parallel to our race-
mic synthesis, we investigated an asymmetric approach to 
(+)-stephadiamine. Since the benzylic quaternary stereo-
center directs the formation of all others stereocenters, we 
focused on the asymmetric allylation of 3. Formation of a 
chiral imine/enamine and reaction with a variety of elec-
trophiles was unsuccessful.[26] Therefore, we turned to-
ward modern transition metal catalysis to install the ben-
zylic quaternary stereocenter (Scheme 4).[27] The asym-
metric Tsuji allylation was investigated with a variety of 
chiral ligands such as (S)-t-Bu-PHOX (L1), (S)-CF3-t-Bu-
PHOX (L2), (S)-QUINAP (L3), (R,R)- and (S,S)-DACH-
Phenyl Trost ligand (L4), (R,R)-DACH-Naphthyl Trost 
ligand (L5) and (R,R)-ANDEN-Phenyl Trost ligand (L6, 
Table 1). These were used in different solvents and at 
varying concentrations and temperatures. In an initial 
screening, we found that a 1:2 mixture of toluene and 
hexane was the best solvent, providing the highest ee 
value across all ligand classes. The starting material was 
consumed in all cases and no side-products were ob-
served. 
The ligand (S)-t-Bu-PHOX only gave 6% ee, whereas the 
electron-deficient congener (S)-CF3-t-Bu-PHOX provided 
38% ee (entries 1 and 2). (S)-QUINAP gave a very low ee 
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 of 11% (entry 3), whereas the C2-symmetric (R,R)-
DACH-Phenyl Trost ligand gave the highest ee value 
(entry 6). Related Trost ligands resulted in a decrease of 
ee values (entries 4 and 5). Therefore, we decided to op-
timize the reaction for the DACH-Phenyl Trost ligand. It 
was found that keeping the ligand/Pd2(dba)3 ratio exactly 
to 2.2:1 was crucial to obtain a good ee (entry 5). In addi-
tional experiments, we determined that when using this 
ligand, the reaction went to completion within minutes 
and therefore the reaction time could be shortened to 5 
min (entry 6). Ultimately, treatment of the allylic car-
bonate 31 with Pd2(dba)3 in the presence of chiral bis-
phosphine ent-L6 gave (R)-8 in 97% yield and 66% ee 
(see SI for details).[28] After a single recrystallization we 
obtained an almost enantiomerically pure product, the 
absolute configuration of which could by established by 
X-ray crystallography. 
Table 1 Optimization of conditions for the asym-
metric  decarboxylative Tsuji allylation. 
 
 
Entry ligand [M] T [°C] 
time 
[min] ee
 
1 L1 0.03 rt 120 6% 
2 L2 0.03 rt 120 38% 
3a) L3 0.03 rt 120 11% 
4 L4 0.03 rt 120 29% 
5 L5 0.03 rt 120 27% 
6 L6 0.03 −10 120 59% 
7 L6 0.03 −10 120 66% 
8a)b) ent-L6 0.003 −10 5 66% 
a(R)-8 was observed as the major enantiomer. bConditions: enol car-
bonate (1.0 equiv), Pd2(dba)3 or Pd2(dba)3·CHCl3 
(4−10 mol%), ligand (7−12 mol%) in 1:2 toluene:hexane, in glovebox. 
the reaction gave the desired (R)-enantiomer in 97% yield. The enantio-
meric excess of this sample could be enriched to 98% ee after recrystal-
lization 
In an effort to improve the enantioselectivity of the reac-
tion, we turned our attention towards enol catalysis, 
which was recently introduced by List and co-workers[29] 
and allows for the direct regio- and enantioselective func-
tionalization of unsymmetrical ketones. This is achieved 
by employing a chiral phosphoric acid, which selectively 
forms the most substituted enol, followed by asymmetric 
reaction with an appropriate electrophile. Under the pre-
viously reported conditions,[27b] which employ a palladi-
um (0) source and (S)-TRIP (cat. A) as a catalyst, 32 
reacted smoothly with allyl methyl carbonate (>95% 
conversion, entry 1, Table 2). The desired product (S)-8 
was isolated in 84% enantiomeric excess. Upon switching 
to (S)-H8-TRIP (cat. B) as a catalyst, we were able to 
increase the enantioselectivity to 86% ee (entry 3).  
Table 2 Optimization of conditions for the direct 
asymmetric α-allylation via enol catalysis. 
 
 
Entrya) cata-
lyst 
[M] T [°C] time [min] ee
 
1 A 0.05 rt 18 84% 
2 A 0.025 rt 18 85% 
3 B 0.05 rt 18 86% 
4 B 0.025 rt 36 88% 
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 5 B 0.01 rt 96 89% 
6 B 0.025 15 96 89% 
7b) B 0.025 15 96 88.5% 
8c) B 0.01 15 96 93% 
9d) ent-B 0.02 10 96 90% 
aConditions: allyl carbonate (1.0 equiv), Pd2(dba)3 (2.5 mol%), chiral 
acid catalyst A or B (10 mol%), t-BuXPhos (11 mol%) in cyclohexane. 
Full conversion by 1H-NMR was observed unless otherwise noted. (a) 
Methylcyclohexane was used as solvent; (b) 63% conversion (deter-
mined by 1H NMR), 63% isolated yield; (c) 85% conversion (deter-
mined by 1H NMR), 81% isolated yield 
Upon further optimization of the reactions conditions, the 
desired product was isolated in 63% yield (97% brsm) 
and 93% ee (entry 8) or in 81% yield (96% brsm) with 
90% ee (entry 9).  
CONCLUSIONS. In summary, we have achieved the 
first synthesis of the unusual alkaloid stephadiamine (3), 
in racemic form. Our synthesis is marked by a practical β-
tetralone synthesis, the facile construction of the benzylic 
quaternary center through twofold alkylation, and a re-
markably efficient cascade to forge the azapropellane core 
of 3. The installation of the α-amino lactone moiety 
proved to be difficult but could eventually be achieved 
using a very small base and electrophile. It also required a 
carefully orchestrated sequence of oxidation and reduc-
tions in a densely functionalized setting. Finally, we have 
elaborated a pathway for the asymmetric synthesis of 
stephadiamine. The building blocks developed in this 
context, (R)-8 and (S)-8, could serve as valuable interme-
diates in the synthesis of a variety of hasubanan and mor-
phine alkaloids, respectively. 
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